ACE-2 and Immune System Changes in Smokers May Underlie COVID-19 Vulnerability

Clinicians report that people with pre-existing conditions such as cardiac disease, hypertension, and diabetes are at higher risk of mortality from COVID-19. With tobacco smoking being the leading cause of preventable death worldwide, it is surprising that smokers are underrepresented in hospital records1. While hospital record data gives insight into the risk factors that influence … Read more

Channeling Health Care Delivery and Implementation Science in Cardiology for Improved Outcomes

The opening session for AHA21 was nothing sort of inspirational. In the opening session, a quote by Dr. Keith Ferdinand, Professor of Medicine and Chair of Preventative Cardiology at Tulane University, really stuck with me. The topic was how is the field of medicine adjusting in the midst of the challenges faced and inequities uncovered … Read more

Summary of COVID-19 Medications

The past year has seen tremendous changes due to the coronavirus 2019 (COVID-19) pandemic across multiple levels. While behavioral changes and social isolation helped with limiting the spread of the disease, certain medications were studied and have been shown to be of benefit in COVID-19 patients. In this article, we summarize some of these medications, … Read more

Trends in COVID-19 in-hospital mortality: Insights from the AHA COVID-19 CVD registry

Information on the survival trends of hospitalized COVID-19 patients is important for physicians to identify trends and track the efficacy of hospital-based care in real-world practice. The American Heart Association’s (AHA) COVID-19 Cardiovascular Disease (CVD) Registry was put in place in April 2020 with the objective of improving nation-wide surveillance of hospitalized patients with COVID-19.1 … Read more

COVID-19 and BMI – What Have We Learned? More insights from the United Kingdom

The COVID-19 pandemic has skyrocketed many fields of healthcare – basic science research, outcome-based research, and epidemiological factors affecting healthcare. We already know obesity affects >4 in 10 adults in the United States and contributes to diabetes, heart disease, ultimately leading to increased morbidity and mortality1.  Based on prior experience, we have learned that obesity … Read more

Can Vitamin C Prevent COVID-19?

The outbreak of COVID-19 has created a global public health crisis. Our knowledge continues to be limited about the protective factors of this infection. Therefore, preventive health measures that can reduce the risk of infection, and halt the progression and severity of symptoms and complications related to COVID-19 are desperately needed. In the midst of … Read more

To Vaccinate or Not Against COVID-19 During Pregnancy: A Pregnant Cardiology Fellow’s Humble Perspective

When news of the approval of the Pfizer vaccine surfaced, I felt a sense of anxiety. There was no data on pregnant women in the COVID-19 vaccine trials. As a medical professional, we have been trained to apply for evidenced-based medicine and baseline patient characteristics of trial participants to the patients we plan to treat. … Read more

Reflections of 2020: adaptations and lessons learned

2020 came, a pandemic hit, and 2020 left. It was an extraordinary year in which words such as unprecedented, exponential and social distancing forced their way into our ordinary vocabulary. Hopefully, we won’t have to live another year like that in our lifetimes, but let’s exercise some cautious optimism in that respect. It took a … Read more